Skip to content
Friday 7 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,923.88
+0.52%
DAX
26,364.38
+0.86%
CAC 40
8,728.50
+0.33%
STOXX 50
6,536.30
+0.52%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE

healthcare

  • London-listed healthcare services firm hit by cyberattack

    Markets

    Shares in Craneware tumbled in early trading on Monday as the healthcare services firm revealed it had been hit by a cyberattack. The AIM-listed business said the incident involved “unauthorised access to a subset of its data environment”. Early investigations suggest “a significant volume of file names were viewed and exfiltrated”. Employee data as well [...]

    Assura has been the subject of a ferocious bidding war for nearly six months
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare

    Swiss pharmaceutical giant Novartis has agreed to buy London-based biotech Myricx Bio for up to $1.5bn (£1.1bn) as global drugmakers continue deploying billions into promising biotech firms ahead of an estimated $450bn wave of patent expiries over the next decade. The deal will see Novartis pay $1.1bn upfront, with a further $400m tied to development [...]

    Hikma produces generic drugs
  • GSK says AI is reshaping drug pipeline as Nuvalent deal hits shares

    Tech

    GSK has said agentic AI is already affecting every asset in its pipeline, as pharmaceutical firms race to use the technology to cut the cost and risk of developing new medicines. Speaking at London Tech Week in Tuesday, Eyal Itskovits, GSK’s director of AI and machine learning, said that the technology has officially become a [...]

    GSK said total sales fell by two per cent in the third quarter
  • NHS gives Palantir wider access to patient data amid growing backlash

    May 11, 2026

    NHS England has expanded access to sensitive patient data for external contractors working on its controversial Palantir-backed data. The move has sparked concerns over privacy for such sensitive data, and the growing influence of American Big Techs inside the UK’s health service. According to the Financial Times, internal briefing documents show NHS officials approved new [...]

  • Howard de Walden Estate splashes £50m on Harley Street property deals

    April 28, 2026

    The Howard de Walden Estate has spent £50m on acquisitions in the Harley Street neighbourhood, Morning Wire can reveal, as it tightens its dominance over the capital’s private health hub. The property company has acquired three long leaseholds in Harley Street and Wimpole Street, with a combined 50,000 sq ft footprint, featuring a blend of [...]

  • Chip makers and defence contractors power profit upgrade for London tech stock Renishaw

    April 20, 2026

    London-listed engineer Renishaw upped its profit guidance on Monday, sending its shares to the top of the FTSE 250, helped by demand from defence contractors and chipmakers. The Gloucestershire-based precision tech firm is known for its precision equipment used in the lithography process of making microprocessors. On Monday, it pointed to “a substantial expansion” of [...]

  • St John Ambulance receives Health Lottery Foundation grant to extend Young Responders programme

    April 20, 2026  |  Sponsored

    First aid and healthcare charity to deliver essential first aid initiative targeted at young people across the East Midlands for the first time. Thanks to players of The Health Lottery, St John Ambulance has received a grant of nearly a quarter of a million pounds from the Health Lottery Foundation to expand its Young Responders programme [...]

  • Exclusive: NHS must keep medicine clawback down or lose investment, says weight-jab boss

    February 18, 2026

    The NHS must keep its medicines clawback tax low and predictable or else risk disrupting the rollout of weight-loss drugs in the UK, Novo Nordisk’s UK chief has said.  Sebnem Avsar Tuna, general manager of UK operations for the Ozempic and Wegovy maker, told Morning Wire the Government must keep in place the current ceiling [...]

  • Private medical insurance claims rise as City workers seek quicker care

    January 26, 2026

    Diagnostic tests top private medical insurance claims as City workers increasingly seek coverage for everyday health needs. According to data from Howden, diagnostic tests and scans are number one across all categories, except for those over 65. This comes as the NHS waiting list has started to fall in recent months, yet 7.31m people across [...]

  • Wes Streeting: Progress on NHS delays as private insurance soars

    January 22, 2026

    Employer-provided health insurance coverage has reached a 30-year high, with 4.8m people now covered, as businesses ramped up employment benefits amid the NHS backlog. UK health insurers paid out a record £4bn in 2024, averaging £11m every day, according to new figures by the ABI. Despite NHS data showing that the waiting list fell by [...]

Posts pagination

  • Page 1
  • Page 2
  • Page 3
  • …
  • Page 7
  • Next

Trending Articles

  • Revolut founder’s wealth set to balloon amid talks of share award at $500bn valuation

  • Rupert Lowe axes pensions triple lock and pledges tax cuts in economic plan

  • Liverpool owners tipped to sell – but not to Amazon boss Bezos – by former CEO

  • As it happened: Stocks rise as oil fluctuates after Red Sea attack; US-Iran deal ‘being circulated’

  • WPP slashes jobs as revenue continues to fall

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook